26 May 2013
Keywords: cv, thera, initiates, ranexa, study, therapeutics, initiated
Article | 09 August 2004
CV Therapeutics has initiated an approval-enabling study of Ranexa(ranolazine) which, if successful, could support approval of the drug
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
9 August 2004
5 April 2004
24 May 2013
© 2013 thepharmaletter.com